pyrimethamine has been researched along with Anorexia in 3 studies
Maloprim: contains above 2 cpds
Anorexia: The lack or loss of APPETITE accompanied by an aversion to food and the inability to eat. It is the defining characteristic of the disorder ANOREXIA NERVOSA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mefloquine (MQ) has been used for the treatment of malaria since the mid-1980s, first as monotherapy or as fixed combination with sulfadoxine-pyrimethamine (MSP) and since the mid-1990s in combination with artesunate." | 7.85 | Adverse effects of mefloquine for the treatment of uncomplicated malaria in Thailand: A pooled analysis of 19, 850 individual patients. ( Lee, SJ; Luxemburger, C; Nosten, F; Price, RN; Ter Kuile, FO, 2017) |
| "Mefloquine (MQ) has been used for the treatment of malaria since the mid-1980s, first as monotherapy or as fixed combination with sulfadoxine-pyrimethamine (MSP) and since the mid-1990s in combination with artesunate." | 3.85 | Adverse effects of mefloquine for the treatment of uncomplicated malaria in Thailand: A pooled analysis of 19, 850 individual patients. ( Lee, SJ; Luxemburger, C; Nosten, F; Price, RN; Ter Kuile, FO, 2017) |
| " Participants were actively monitored for adverse events for the first 14 days after each treatment, and then passively followed until their next study medication treatment, or withdrawal from study." | 2.73 | Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children. ( Clark, TD; Dorsey, G; Jagannathan, P; Kamya, MR; Maiteki-Sebuguzi, C; Njama-Meya, D; Nzarubara, B; Rosenthal, PJ; Staedke, SG; Talisuna, AO; Yau, VM, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, SJ | 1 |
| Ter Kuile, FO | 1 |
| Price, RN | 1 |
| Luxemburger, C | 1 |
| Nosten, F | 1 |
| Maiteki-Sebuguzi, C | 1 |
| Jagannathan, P | 1 |
| Yau, VM | 1 |
| Clark, TD | 1 |
| Njama-Meya, D | 1 |
| Nzarubara, B | 1 |
| Talisuna, AO | 1 |
| Kamya, MR | 1 |
| Rosenthal, PJ | 1 |
| Dorsey, G | 1 |
| Staedke, SG | 1 |
| Hindmarsh, JR | 1 |
| Hall, RR | 1 |
| Kulatilake, AE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Longitudinal Comparison of Combination Antimalarial Therapies in Ugandan Children: Evaluation of Safety, Tolerability, and Efficacy[NCT00123552] | Phase 3 | 601 participants (Actual) | Interventional | 2004-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for pyrimethamine and Anorexia
| Article | Year |
|---|---|
Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children.
Topics: Amodiaquine; Anorexia; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artes | 2008 |
2 other studies available for pyrimethamine and Anorexia
| Article | Year |
|---|---|
Adverse effects of mefloquine for the treatment of uncomplicated malaria in Thailand: A pooled analysis of 19, 850 individual patients.
Topics: Adolescent; Adult; Anorexia; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Dizzi | 2017 |
Renal cell carcinoma: a preliminary clinical trial of methodichlorophen (D.D.M.P.).
Topics: Adenocarcinoma; Aged; Anorexia; Attention; Female; Headache; Humans; Kidney Neoplasms; Male; Middle | 1979 |